Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00573716 · ClinicalTrials.gov registry record

Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents

A clinical trial, sponsored by Creighton University.

Completed
Registry status
60
Enrollment target

NCT00573716 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00573716 has completed, sponsored by Creighton University.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

This study examines if the use of antipsychotic medications might contribute to an interruption in bone mineral development and/or a reduction in bone mineral content in adolescents.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2006-10
Est. Completion 2009-10

Sponsor

Creighton University

98 total trials

What the Registry Record Tells You About NCT00573716

The ClinicalTrials.gov registry entry for NCT00573716 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00573716 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00573716 about?

NCT00573716 is a clinical study titled "Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents". This study examines if the use of antipsychotic medications might contribute to an interruption in bone mineral development and/or a reduction in bone mineral content in adolescents.

What is the current status of trial NCT00573716?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2006-10. Estimated completion is 2009-10.

Who is sponsoring clinical trial NCT00573716?

This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.